Commercialisation & Intellectual Property Committee

The role of the Commercialisation and Intellectual Property Committee (CIPC) is to advise the APC’s Executive Management Group on technology transfer, recommend and oversee procedures for the capture, protection and exploitation of intellectual property arising from the Research Programmes and notification of such IP to APC Industry Partners, and to facilitate any disputes that may arise regarding the ownership of Foreground IP.

The CIPC typically meets twice a year and comprises the following membership:

• Mr Martin Mullins
  Vice President, Whitehead Institute for Biomedical Research, Cambridge, MA, USA (Chairperson)
• Dr Tim Roche
  Director of Technology Transfer, UCC
• Dr Miriam Walsh
  Director of Intellectual Property, Teagasc
• Dr Christian Stafford
  Enterprise Ireland
• Dr. Derek John
  TTO Commercialisation Case Manager, UCC
• Dr Brendan Curran
  APC IP Manager
• Dr Sally Cudmore
  APC General Manager